ClearBridge Investments
CBAY

ClearBridge Investments’s Cymabay Therapeutics CBAY Stock Holding History

ClearBridge Investments’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,760
Closed -$17K – 1207
2014
Q4 		$17K Hold
1,760
– – ﹤0.01% 1082
2014
Q3 		$12K Buy
+1,760
New +$10.8K ﹤0.01% 1095

Other funds holding CBAY

LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments's CBAY Position: Q1 2015 in Review

ClearBridge Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2015, closing a stake of 1,760 shares — an estimated $17K sold.

ClearBridge Investments first reported a position in CBAY in Q3 2014 and held it in 2 quarters. The position peaked at $17K in Q4 2014. 28 funds tracked by Wall St. Rank hold CBAY as of Q1 2015.

  • ClearBridge Investments reported no remaining Cymabay Therapeutics position as of Q1 2015 after selling out during the quarter.
  • ClearBridge Investments sold 1,760 Cymabay Therapeutics shares in Q1 2015, an estimated $17K.
  • ClearBridge Investments first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 2 quarters.
  • ClearBridge Investments's Cymabay Therapeutics position peaked at $17K in Q4 2014.
  • 28 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2015.

Based on ClearBridge Investments's 13F filing for Q1 2015, filed 15 May 2015.